A new weekday brief from the newsroom behind Pink Sheet, Scrip and In Vivo, distilling the day's most consequential drug development, regulatory and dealmaking news into a single, six-minute read
NEW YORK, Aug. 27, 2026 /PRNewswire-PRWeb/ -- Norstella, the leading global provider of AI-enabled pharma intelligence solutions, today announced the launch of Capsul, a free daily intelligence brief for the pharmaceutical and biotech industry. Each edition takes a single theme and adapts it into one flowing read that a busy professional can finish in minutes, leaving them with a clear picture of what moved, why it matters and what to watch next, without opening a single link.
Capsul comes from Norstella's News and Insights division, the reporters and editors behind the industry's most trusted names, including Pink Sheet, Scrip and In Vivo. It is built for the full span of the industry, from the business development director at an early-stage biotech to the 30-year veteran, on the premise that both deserve the same thing: coverage that is accurate to the specialist and a pleasure to read.
One edition lands each weekday morning, built around a single theme, moving across the week from clinical data to the regulators to the therapeutic areas that matter most. By Friday, a reader has seen the industry from every side that matters and never spent more than six minutes getting there. The editions carry a distinct voice, but the accuracy floor is non-negotiable, held to the editorial standards of Norstella News & Insights.
"Capsul is drawn from the same newsroom expertise customers have relied on for decades," said Suzanne Caruso, President, Clinical and Strategic Intelligence, Norstella. "We are taking that rigor and making it a daily habit anyone in pharma or biotech can pick up in six minutes."
"Intelligent insights can be hard to come by," Karen Coleman, Vice President of Norstella's News & Insights division, said. "We have a market-leading heritage of specialist news products delivering rich analysis for our enterprise customers. Capsul gives readers an opportunity to ingest a daily dose of these insights in a different style and format."
Capsul is free to read during a limited launch period. The latest editions are available now at capsul.news.
About Norstella
Norstella is the AI company for biopharma's highest-stakes decisions. A global life sciences company trusted by every Top 100 pharma company and industry experts the world over, Norstella unites market-leading brands — Citeline, Evaluate, MMIT, Panalgo, Skipta and The Dedham Group — turning decision-grade data, insights and expertise into AI you can act on, from pipeline to patient. With the patient always at the center, Norstella is advancing the path to life-changing therapies for patients and providers. Follow us on LinkedIn.
For media inquiries, please contact:
Media Contact
Diffusion PR for Norstella, Norstella, 1 (888) 200-9288, [email protected], www.norstella.com
SOURCE Norstella
Share this article